Treace Medical Concepts, Inc. (TMCI) — 8-K Filings
All 8-K filings from Treace Medical Concepts, Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (10)
- 8-K Filing — May 8, 2026
-
Treace Medical Concepts Files 8-K: Operations, Officers, and Reg FD
— Apr 9, 2026 Risk: medium
Treace Medical Concepts, Inc. filed an 8-K on April 9, 2026, reporting on results of operations and financial condition as of April 8, 2026. The filing also dis -
Treace Medical Concepts Enters New Agreements, Terminates Others
— Dec 18, 2025 Risk: medium
On December 16, 2025, Treace Medical Concepts, Inc. entered into a material definitive agreement and terminated another. The company also created a direct finan -
Treace Medical Concepts Files 8-K
— May 21, 2025 Risk: low
On May 21, 2025, Treace Medical Concepts, Inc. filed an 8-K report. The filing primarily concerns the submission of matters to a vote of security holders and in -
Treace Medical Concepts Files 8-K on Officer/Director Changes
— Apr 7, 2025 Risk: medium
Treace Medical Concepts, Inc. filed an 8-K on April 7, 2025, reporting on the departure of directors or certain officers, the election of directors, the appoint -
Treace Medical Concepts Files 8-K
— Jan 13, 2025 Risk: low
Treace Medical Concepts, Inc. filed an 8-K on January 13, 2025, to report current information. The filing confirms the company's principal executive offices are -
Treace Medical Concepts Files 8-K
— Oct 15, 2024 Risk: low
On October 14, 2024, Treace Medical Concepts, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the submission of Financial S -
Treace Medical Concepts Holds Shareholder Vote
— May 22, 2024 Risk: low
On May 21, 2024, Treace Medical Concepts, Inc. filed an 8-K report detailing a shareholder meeting where proposals were submitted for a vote. The company, incor -
TREACE MEDICAL CONCEPTS Confirms Nasdaq Listing & Public Status
— Jan 10, 2024
TREACE MEDICAL CONCEPTS, Inc. filed an 8-K on January 9, 2024, to disclose that it is a publicly traded company with its Common Stock, $0.001 par value per shar -
TREACE MEDICAL CONCEPTS Files 8-K on Operations & Financials
— Jan 8, 2024
TREACE MEDICAL CONCEPTS, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition. This filing indicates that the co
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX